Accuracy of the G-8 geriatric-oncology screening tool for identifying vulnerable elderly patients with cancer according to tumour site: The ELCAPA-02 study

被引:61
|
作者
Liuu, Evelyne [1 ]
Canoui-Poitrine, Florence [2 ,3 ]
Tournigand, Christophe [4 ]
Laurent, Marie [1 ,2 ]
Caillet, Philippe [1 ,2 ]
Le Thuaut, Aurelie [2 ,3 ,5 ]
Vincent, Helene [6 ]
Culine, Stephane [7 ]
Audureau, Etienne [2 ,3 ]
Bastuji-Garin, Sylvie [2 ,3 ,5 ]
Paillaud, Elena [1 ,2 ]
机构
[1] Hop Henri Mondor, AP HP, Dept Internal Med & Geriatr, Onco Geriatr Clin, F-94010 Creteil, France
[2] UPEC, LIC EA 4393, F-94010 Creteil, France
[3] Hop Henri Mondor, AP HP, Dept Publ Hlth, F-94010 Creteil, France
[4] Hop Henri Mondor, AP HP, Dept Med Oncol, F-94010 Creteil, France
[5] Hop Henri Mondor, AP HP, Clin Res Unit URC Mondor, F-94010 Creteil, France
[6] Hop Paul Brousse, AP HP, Dept Geriatr, F-94804 Villejuif, France
[7] Hop St Louis, AP HP, Dept Med Oncol, F-75010 Paris, France
关键词
Cancer; Elderly; Screening; Accuracy; Validation; OLDER PATIENTS; CONTROLLED-TRIALS; FRAILTY; ADULTS; METAANALYSIS; ILLNESS; SCALE;
D O I
10.1016/j.jgo.2013.08.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background/Objective: G-8 screening tool showed good screening properties for identifying vulnerable elderly patients with cancer who would benefit from a comprehensive geriatric assessment (CGA). We investigated whether tumour site and metastatic status affected its accuracy. Materials and Methods: Design: Cross-sectional analysis of a prospective cohort study. Setting: Geriatric-oncology clinics of two teaching hospitals in the urban area of Paris. Participants: Patients aged 70 or over (n = 518) with breast (n = 113), colorectal (n = 108), urinary-tract (n = 89), upper gastrointestinal/liver (n = 85), prostate (n = 69), or other cancers (n = 54). Measurements: Reference standard for diagnosing vulnerability was the presence of at least one abnormal test among the Activities of Daily Living (ADLs), Instrumental ADL, Mini-Mental State Examination, Mini Nutritional Assessment, Cumulative Illness Rating Scale-Geriatrics, Timed Get-Up-and-Go, and Mini-Geriatric Depression Scale. Sensitivity, specificity and likelihood ratios of G-8 scores 5 14 were compared according to tumour site and patient characteristics. Results: Median age was 80; 48.2% had metastases. Prevalence of vulnerability and abnormal G-8 score was 84.2% (95% confidence interval [95% CI], 81-87.3) and 79.5% (95% CI, 76-83).
引用
收藏
页码:11 / 19
页数:9
相关论文
共 19 条
  • [1] SURVIVAL OF ELDERLY PATIENTS WITH ENDOMETRIAL CANCER - PREDICTED BY PREOPERATIVE G-8 GERIATRIC SCREENING TOOL
    Anic, K.
    Altehoefer, C.
    Schmidt, M. W.
    Krajnak, S.
    Schwab, R.
    Linz, V.
    Westphalen, C.
    Hartmann, E. K.
    Schmidt, M.
    Hasenburg, A.
    Battista, M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A83 - A83
  • [2] Screening older cancer patients: first evaluation of the G-8 geriatric screening tool
    Bellera, C. A.
    Rainfray, M.
    Mathoulin-Pelissier, S.
    Mertens, C.
    Delva, F.
    Fonck, M.
    Soubeyran, P. L.
    ANNALS OF ONCOLOGY, 2012, 23 (08) : 2166 - 2172
  • [3] PFS OF ELDERLY OVARIAN CANCER PATIENTS MIGHT BE PREDICTED BY G-8 GERIATRIC SCREENING TOOL - RESULTS OF A RETROSPECTIVE COHORT STUDY
    Anic, K.
    Birkert, S.
    Schwab, R.
    Schmidt, M. W.
    Linz, V.
    Krajnak, S.
    Heimes, A-S
    Schmidt, M.
    Westphalen, C.
    Hartmann, E. K.
    Hasenburg, A.
    Battista, M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A215 - A216
  • [4] The G8 Screening Tool Detects Relevant Geriatric Impairments and Predicts Survival In Elderly Blood Cancer Patients
    Stauder, Reinhard
    Mitrovic, Martina
    Gastl, Guenther A.
    Hamaker, Marije E.
    BLOOD, 2013, 122 (21)
  • [5] G-8 Geriatric Screening Tool Independently Predicts Progression-Free Survival in Older Ovarian Cancer Patients Irrespective of Maximal Surgical Effort: Results of a Retrospective Cohort Study
    Anic, Katharina
    Birkert, Sophie
    Schmidt, Mona Wanda
    Linz, Valerie Catherine
    Heimes, Anne-Sophie
    Krajnak, Slavomir
    Schwab, Roxana
    Schmidt, Marcus
    Westphalen, Christiane
    Hartmann, Erik Kristoffer
    Hasenburg, Annette
    Battista, Marco Johannes
    GERONTOLOGY, 2022, 68 (10) : 1101 - 1110
  • [6] Is vulnerable elders survey 13 (VES-13) a sensitive and specific screening tool for identifying vulnerable/frail elderly cancer patients compared to full comprehensive geriatric assessment (CGA)?
    Falci, C.
    Basso, U.
    Fiduccia, P.
    Brunello, A.
    Baretta, Z.
    Solda, C.
    Lamberti, E.
    Bozza, F.
    Capovilla, E.
    Jirillo, A.
    Monfardini, S.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2009, 72 : S19 - S20
  • [7] Diagnostic accuracy of the geriatric screening tools G8 and modified G8 in older patients with lung cancer: A diagnostic performance study
    Bech, Danny
    Lietzen, Lone Winther
    Meldgaard, Peter
    Ryltoft, Anne-Kathrine
    Orum, Marianne
    JOURNAL OF GERIATRIC ONCOLOGY, 2024, 15 (02)
  • [9] ELAN-ONCOVAL (Elderly Head and Neck Cancer-Oncology Evaluation) study: Evaluation of the G8 screening tool and the ELAN geriatric evaluation (EGE) for elderly patients (pts) with head and neck squamous cell carcinomas (HNSCC).
    Mertens, Cecile
    Le Caer, Herve
    Ortholan, Cecile
    Blot, Emmanuel
    Even, Caroline
    Rousselot, Hubert
    Peyrade, Frederic
    Sire, Christian
    Cupissol, Didier
    Pointreau, Yoann
    Debourdeau, Philippe
    Rolland, Frederic
    Fayette, Jerome
    Capitain, Olivier
    Sun, Xu Shan
    Debbah, Moufida
    Boulahssass, Rabia
    Schwob, Dominique
    Auperin, Anne
    Guigay, Joel
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [10] A Questionnaire Study to Assess the Value of the Vulnerable Elders Survey, G8, and Predictors of Toxicity as: Screening Tools for Frailty and Toxicity in Geriatric Cancer Patients
    Hentschel, Leopold
    Rentsch, Anke
    Lenz, Felicitas
    Hornemann, Beate
    Schmitt, Jochen
    Baumann, Michael
    Ehninger, Gerhard
    Schuler, Markus
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 (04) : 210 - 216